-
Mashup Score: 2SCS Researcher Develops Metagenomic Profiling Method - 9 day(s) ago
A new k-mer sketching metagenomic profiler allows scientists to analyze genomic data more quickly and precisely than other profilers.
Source: www.cmu.eduCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 12
Researchers advance CAR T cell therapy for solid tumors by innovating ways to overcome the unique barriers of solid tumor environments, with promising clinical results.
Source: www.news-medical.netCategories: General Medicine News, Future of MedicineTweet-
@UgiUslu @carlhjune @PennMedicine CAR T cell therapy breakthroughs bring new hope for treating solid tumors #NBTintheNews https://t.co/gAj0JRbCxX
-
-
Mashup Score: 5A bacterial neoantigen cancer vaccine - 9 day(s) ago
Nature Biotechnology – A bacterial neoantigen cancer vaccine
Source: www.nature.comCategories: General Medicine News, Future of MedicineTweet-
Research Highlight: A bacterial neoantigen cancer vaccine https://t.co/JoQ6TOZUN1
-
-
Mashup Score: 19
Researchers at ETH Zurich have combined two gene editing methods. This enables them to quickly investigate the significance of many genetic mutations involved in the development and treatment of cancer.
Source: ethz.chCategories: General Medicine News, Future of MedicineTweet-
@randall_platt @olivier_belli @k_karava @ETH_en @ETH_BSSE @BRC_CH @UniBasel @NCCR_MSE Using CRISPR to decipher whether gene variants lead to cancer #NBTintheNews via @ETH_en https://t.co/PaLXxzNOgQ
-
-
Mashup Score: 270Directed evolution of engineered virus-like particles with improved production and transduction efficiencies - 10 day(s) ago
Nature Biotechnology – Engineered virus-like particles are improved through directed evolution.
Source: www.nature.comCategories: General Medicine News, Future of MedicineTweet-
Directed evolution of engineered virus-like particles with improved production and transduction efficiencies https://t.co/wCW5GcqwgF https://t.co/1GnqdSWhAK
-
-
Mashup Score: 103
Nature Biotechnology – Thousands of rare oncogene variants are evaluated using multimodal gene editing screens.
Source: www.nature.comCategories: General Medicine News, Future of MedicineTweet-
Multimodal scanning of genetic variants with base and prime editing https://t.co/S2poPOSxQR https://t.co/UH54DM3ii5
-
-
Mashup Score: 202Transcriptome-scale RNA-targeting CRISPR screens reveal essential lncRNAs in human cells - 11 day(s) ago
Massively parallel CRISPR-Cas13 screens in multiple human cell lines uncover universally essential and context-specific essential lncRNAs that exhibit dynamic expression during development and in specific tumor types, and these lncRNAs function independently from neighboring protein-coding genes.
Source: www.cell.comCategories: General Medicine News, Future of MedicineTweet-
A CRISPR screen targeting RNA identifies essential lncRNAs in human cells, revealing lncRNAs whose expression correlates with the survival of tumors, identifying new biomarkers and potential targets for therapeutics https://t.co/o8iK1OSaq4 #NBThighlight
-
-
Mashup Score: 22
Nature Biotechnology – Amyloid deposits are present in the brains of cognitively impaired individuals, but also accumulate throughout the body. Some biotechs aim to keep these misfolded proteins in…
Source: www.nature.comCategories: General Medicine News, Future of MedicineTweet-
Amyloid is everywhere, but new treatments could stop the toxic build up https://t.co/qa2jUxchib https://t.co/htQa8S0adt
-
-
Mashup Score: 19
Understanding how gene mutations influence protein-protein interactions across the interactome is critical to further diagnostic and drug discovery research.
Source: www.lerner.ccf.orgCategories: General Medicine News, Future of MedicineTweet-
@haiyuanyu @FeixiongCheng @CornellCALS @weillinstitute @CCLRI @CleClinicLCM @cwru @columbiacancer @ECNUER @BrighamWomens New AI tool predicts protein-protein interaction mutations in hundreds of diseases #NBTintheNews via @CCLRI https://t.co/OReWgMptuL https://t.co/xCuNWM4ufk
-
-
Mashup Score: 74CRISPR Nobelists surrender their own European patents - 15 day(s) ago
Nature Biotechnology – A strategic move by lawyers acting for Doudna and Charpentier is the latest twist in the battleground for CRISPR–Cas9 technology.
Source: www.nature.comCategories: General Medicine News, Future of MedicineTweet-
CRISPR Nobelists surrender their own European patents https://t.co/zOeiH68izq
-
.@SCSatCMU researcher develops metagenomic profiling method #NBTintheNews https://t.co/94X3Ko2GHN https://t.co/AS9j25Oecx